SCHEMBL6050860

SCHEMBL6050860

C1=C(N2CCCN2)[N]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179932 0.69 CHKA (0.33)
SCHEMBL3352088 0.69
SCHEMBL9082734 0.67 USP2 (0.34)
SCHEMBL9558323 0.64 LMNA (0.33)
SCHEMBL11401370 0.63 ALOX5 (0.38)
SCHEMBL31339576 0.61 ADRB2 (0.37)
SCHEMBL28486034 0.61 ALDH1A1 (0.50)
SCHEMBL28290847 0.60 ADRB2 (0.53)
SCHEMBL31247759 0.60 LMNA (0.30)
SCHEMBL16667080 0.60 CYP1A2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230062861-A1 PPARg MODULATORS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-03-02 US disclosed
EP-1636232-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA Bioscience nv (BE) 2006-03-22 EP disclosed
WO-2004104005-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA BIOSCIENCE NV (BE) 2004-12-02 WO disclosed